NCT03876470View on ClinicalTrials.gov

Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Hepatitis C
Interventions
OTHER

Hepatitis C treatment as chosen by provider

Participants' providers will determine the type of HCV treatment as appropriate.

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of Virginia

OTHER